Page last updated: 2024-10-26

valproic acid and Glomerulonephritis, IGA

valproic acid has been researched along with Glomerulonephritis, IGA in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Glomerulonephritis, IGA: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, Q1
Liu, J1
Du, YL1
Hao, X1
Ying, J1
Tan, Y1
He, LQ1
Wang, WM1
Chen, N1

Other Studies

1 other study available for valproic acid and Glomerulonephritis, IGA

ArticleYear
Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:2

    Topics: Cell Proliferation; Cells, Cultured; Extracellular Matrix; Glomerulonephritis, IGA; Histone Deacetyl

2016